Caprius, Inc. Enters into Distribution Agreement with Fresenius Medical Care for the Dialysis Market

Business Wire, March 9, 2005

FORT LEE, N.J. -- Caprius, Inc. (OTCBB: CAPR.OB) announced today that its subsidiary, MCM Environmental Technologies, Inc. ("MCM"), entered into a Distribution Agreement with two operating units of Fresenius Medical Care North America ("FMCNA"). The agreement grants a license to use and sell any and all current or future versions of the following products manufactured and/or distributed by MCM; Ster-Cid disinfectant(R), Junior Filter Bags and SteriMed System(R) products. These products will be available for distribution by the FMC-NA domestic sales force for the approximate 4,200 dialysis clinics within the United States, Canada, the Caribbean basin and Bermuda. The SteriMed System products provide an on-site solution to convert red bag infectious medical waste to ordinary black bag waste.

George Aaron, Caprius' CEO, stated: "We value the relationship with Fresenius Medical Care and view this agreement as a strategic opportunity to expand our marketing activities in the growing dialysis market. Both parties look forward to working together and optimizing the synergistic value of this agreement."

Caprius, Inc., headquartered in Fort Lee, NJ, is engaged in manufacturing proprietary equipment for on-site medical waste disposal through its subsidiary, M.C.M. Environmental Technologies, Inc (MCM). The Company's SteriMed units simultaneously shred and disinfect regulated medical waste, reducing its volume up to 90%, and rendering it harmless for disposal as ordinary waste. The SteriMed System is environmentally-friendly and efficiently disinfects the infectious clinical waste, including, among others, sharps, dialyzers, blood lines, bandages, plastic tubing and glass, in a 15 minute cycle. The MCM patented technology is an alternative to hauling and incinerating medical waste. In the U.S., medical waste is a $3 billion market. More information on the Company and MCM can be found at www.caprius.com or www.mcmetech.com.

Fresenius Medical Care North America, a wholly owned subsidiary of Fresenius Medical Care AG, is the world's largest provider of dialysis products and services. More information on Fresenius Medical Care North America can be found at www.fmcna.com or www.fmc-ag.com.

SAFE HARBOR STATEMENT:

The statements made in this press release that are not historical fact are "forward-looking statements" which are based upon current expectations that include a number of risks and uncertainties. Additional factors that could potentially affect the Company's financial results may be found on the Company's filings with the Securities and Exchange Commission (www.sec.gov).